3-hydroxy-3-methylglutaryl-coenzyme a has been researched along with Obesity in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Drotningsvik, A; Flesland, O; Gudbrandsen, OA; Mjøs, SA; Oterhals, Å; Pampanin, D; Vikøren, LA | 1 |
Chen, WC; Ho, CT; Lai, YS; Lin, SH; Lin, SY; Lu, KH; Sheen, LY; Tseng, HC | 1 |
Browne, RW; Carrier, B; Harding, SV; Raslawsky, A; Rideout, TC; Wen, S | 1 |
Kiniwa, M; Matsuura, N; Ohmori, K; Yamada, H; Yamamoto, A; Yasuda, A | 1 |
4 other study(ies) available for 3-hydroxy-3-methylglutaryl-coenzyme a and Obesity
Article | Year |
---|---|
Water-Soluble Fish Protein Intake Led to Lower Serum and Liver Cholesterol Concentrations in Obese Zucker fa/fa Rats.
Topics: Acyl Coenzyme A; Animals; Cholesterol; Dietary Proteins; Fish Proteins; Fishes; Lipid Metabolism; Lipoproteins, HDL; Lipoproteins, LDL; Liver; Male; Obesity; Rats; Rats, Zucker; Receptors, LDL | 2018 |
Garlic essential oil protects against obesity-triggered nonalcoholic fatty liver disease through modulation of lipid metabolism and oxidative stress.
Topics: Acetyl-CoA Carboxylase; Acyl Coenzyme A; Animals; Garlic; Humans; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Oils, Volatile; Oxidative Stress; Plant Oils; Protective Agents; Sterol Regulatory Element Binding Protein 1 | 2014 |
Complementary Cholesterol-Lowering Response of a Phytosterol/α-Lipoic Acid Combination in Obese Zucker Rats.
Topics: Acyl Coenzyme A; Animals; Anticholesteremic Agents; Antioxidants; Bile Acids and Salts; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diet, High-Fat; Dietary Fats; Dietary Supplements; Drug Synergism; Hypercholesterolemia; Intestinal Absorption; Liver; Male; Obesity; Phytosterols; Proprotein Convertase 9; Rats, Zucker; RNA, Messenger; Serine Endopeptidases; Thioctic Acid | 2016 |
Anti-hyperlipidemic action of a newly synthesized benzoic acid derivative, S-2E.
Topics: Acetyl-CoA Carboxylase; Acyl Coenzyme A; Administration, Oral; Animals; Benzoates; Cholesterol; Fatty Acids; Hydroxybenzoate Ethers; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins, VLDL; Liver; Male; Obesity; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Rats, Zucker; Sterols; Suspensions; Triglycerides | 2003 |